Clinical Cancer Research Highlights Potent Antitumor Activity of Repotrectinib in Treatment-Naïve and Solvent-Front Mutation Ros1-Positive Non-Small Cell Lung Cancer

Ads

You May Also Like

Molecular Templates to Present at the UBS Global Healthcare Conference

AUSTIN, Texas, May 15, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq:MTEM) (“Molecular”), a ...

Intellia Therapeutics Announces Second Quarter 2018 Financial Results

Continued to progress lead in vivo program in transthyretin amyloidosis targeting submission of an ...

Aleafia Health Completes Strategic Investment in Australia’s CannaPacific Pty Limited

Global Expansion Underway with 10% Equity Investment in Licensed Cannabis Cultivator CannaPacific among Australia’s ...